Seeking Alpha

Ruthanne Williams Roussel » StockTalks

  • VVUS ED drug OK but not my bag, more on instablog. (One imagines the clinical trial: "Hey, you got it in there! Good going, honey!")
    5 days ago
  • VVUS announces Phase 3 results for erectile dysfunction drug avanafil, a fast-acting PDE5 inhibitor, tomorrow BMO. May be safe with nitrates
    Tue, Nov 17, 2009
  • If you don't like the risk of new obesity drugs, or the risk of existing drugs, then you don't leave yourself many options in the space.
    Mon, Nov 16, 2009
  • If I knew (which I don't) that WSJ blog reflected the thinking of a source within Merck, then I'd say this should bode well for ARNA.
    Mon, Nov 16, 2009
  • WSJ tries to sum up landscape from Merck's POV http://bit.ly/2cTLQt
    Mon, Nov 16, 2009
  • Study focused on docs now prescribing a lot of weight loss meds -- the Holy Grail though is to get it out into general primary care market
    Tue, Nov 10, 2009
  • Study apparently assumed full reimbursement of all options, but included only lorcaserin and drugs already approved now.
    Tue, Nov 10, 2009
  • ARNA says their studies show docs would prescribe lorcaserin, 25% switching from old weight loss drugs 75% new scripts.
    Tue, Nov 10, 2009
  • Bought more VVUS, ARNA and OREX.
    Tue, Nov 03, 2009
  • Puzzler for the p.m.: why only 2 questioners on VVUS call? Was there something better at same time I wasn't invited to?
    Tue, Nov 03, 2009
  • If I'm 5'2" and 200 lbs and I want to slim down, I'm not vain or conceited or self-centered! I'm friggin' realistic!
    Tue, Nov 03, 2009
  • As much as I like being featured at SA, I have to say, I HATE the "vanity" meme.
    Tue, Nov 03, 2009
  • Data on AMLN Phase II study is at their website and my blog, but short version is: comparable to most Phase II obesity studies
    Mon, Nov 02, 2009
  • I thought that was too crude an analogy, so I took it out of the article
    Mon, Nov 02, 2009
  • say my dog poops on the rug once a week, and now he starts doing it twice a week. Yes it does matter!
    Mon, Nov 02, 2009
  • Outtake from article: AMLN says no big deal that their drug is injectable because many diabetics already inject anyway. I don't agree...
    Mon, Nov 02, 2009
  • AMLN news good for all the obesity stocks. It shows there is serious interest among major drug companies in marketing obesity drugs.
    Mon, Nov 02, 2009
  • make that www/obesityinvestor/typepad/com
    Wed, Oct 28, 2009
  • First take will be at www/obesityinvestor.typepead.com
    Wed, Oct 28, 2009
  • I know plenty about topiramate-inspired dopiness, I from study and from personal experience, if I can only remember it that is.
    Wed, Oct 28, 2009
StockTalks by Ticker
A, AMLN, ARNA, BMO, CEO, CMRG, ED, EOD, II, IMO, ITT, JPM, M, NTRI, NYT, OREX, RE, SA, SR, VVUS, WMT, XL